Hamill John
Insider CIK 1559058 · NRX Chief Financial Officer · SVNT SVP, CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NRX NephroGenex, Inc. | A Award | 2015-11-10 | 2015-11-12 | 136,381 | — | $0 | 136,381 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2015-04-30 | 2015-05-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2014-12-12 | 2014-12-15 | 45,000 | — | $0 | 45,000 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2014-08-14 | 2014-08-15 | 24,000 | — | $0 | 24,000 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2014-05-15 | 2014-05-16 | 30,769 | — | $0 | 30,769 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 800 | $0.08 | $64 | 74,313 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 1,000 | $0.08 | $80 | 75,113 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 21,000 | $0.08 | $1.7K | 76,113 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 7,646 | $0.08 | $612 | 66,667 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 1,500 | $0.08 | $120 | 102,113 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 5,000 | $0.08 | $400 | 97,113 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award deriv | 2013-03-05 | 2013-03-07 | 110,000 | — | $0 | 110,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award deriv | 2012-09-24 | 2012-09-26 | 250,000 | $2.92 | $730.0K | 250,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award | 2012-09-24 | 2012-09-26 | 100,000 | $2.92 | $292.0K | 100,000 | SEC↗ |